Thrombokinase has been isolated from bovine plasma in a form that approached electrophoretic homogeneity`and gave a single boundary in the ultracentrifuge.' Such material has four separately measurable activities: 1. activation of prothrombin in the presence of oxalate; 2. activation of prothrombin in the presence of ionic calcium, phospholipid and factor V; 3. activation of chymotrypsinogen; and 4. hydrolysis of tosylarginine methyl ester. The defining property has been taken as the direct, unaided activation of prothrombin, which can be assayed, with thrombokinase. in microgram concentrations. However, thrombokinase can be assayed in nanogram concentrations, provided that the prothrombin is accompanied by ionic calcium, phospholipid and factor V. It is this latter property which has now been preferentially destroyed by chymotrypsin. Moreover, this has been accompanied by a molecular change in the thrombokinase.
Bovine plasma albumin. Crystallized bovine plasma albumin. Armour Pharmaceutical Co., Kankakee, Ill. Coagulation tests. As described. ' Working assay. Essentially as described."5 The five-reagent thrombin-producing mixture contained 0.5 ml. prothrombin (35 units), 0.1 ml. phospholipid, 02 ml. factor V, 0.1 ml. calcium chloride and 0.1 ml. of the thrombokinase to be assayed. Activity was expressed as relative to a standard thrombokinase, which was tested in parallel, in the same system. A relative activity of 100 would mean that the unknown, at a dilution of 1:200,000 caused the system to produce thrombin as fast as the standard thrombokinase at a dilution of 1:2,000.
Thrombokinase (Kinase). Unaided activation of prothrombin in the presence of oxalate. This thrombin-producing mixture was composed of 0.8 ml. prothrombin (212 units), 0.1 ml. O.1M potassium oxalate and 0.1 ml. of the solution to be assayed for thrombokinase. The number of NIH units of thrombin produced in one hour at 28°C. by this mixture was taken as the titer of the solution. This was then multiplied by the dilution of the unknown in the solution that was Thirty grams superfine Sephadex was stirred into 1,400 ml. distilled water and diluted to 1,900 ml. After the suspension had settled for half an hour, the supernatant fluid, with some fine particles still suspended, was removed by aspiration. The thick suspension was stirred with veronal-buffered saline, allowed to settle again; and the supernatant fluid was removed. Dilution with fresh buffer, stirring, settling and removal of supernatant fluid were repeated five times. The thick suspension was then transferred to a flask; and 100 ml. veronal-buffered saline was used to wash residual suspension into the flask. The final suspension was kept at 4-8'C. for one month.
A column of superfine Sephadex G-100, approximately 2.5 x 40 cm. was poured in a Sephadex K 25/45 glass laboratory column, set up in a large, glass-doored refrigerator at 4-5'C. Column flow was downward. A sample applicator was placed on top of the gel; and a Mariotte flask with veronal-buffered saline was connected to the top of the column by a length of tubing. The column was allowed to flow for two days, during which the Mariotte flask was adjusted to maintain a hydrostatic pressure of 11 cm. and a flow-rate of about 10 ml. per hour. Every sample was in veronal-buffered saline; and 1.0 ml. was introduced from a cold tuberculin syringe fitted with a long needle bent at a right angle near its tip. This made it easier to layer the sample beneath the buffer at the bottom of the sample applicator. Collection of 102-drop fractions was begun when 17 small drops (0.5 ml.) had emerged from the outflow tubing, i.e. when about half the sample had entered the column.'0 At the end of the run, the volume of each fraction was measured in a graduate, and found to be close to 3.0 ml. The dead space at the bottom of the column and in the outflow tubing had been determined to be 0.6 ml.; and it was subtracted from the outflow volume. In charting the data, the points were placed at the volume representing the middle of the fractions. For elution volumes, mid-points of the peaks were estimated on the charts, to the nearest 0.1 ml.
RESULTS
The first suggestion of selective inactivation revealed itself as consideration was given to the activation of chymotrypsinogen by thrombokinase.
The fact that activation continued long after active chymotrypsin was demonstrable' indicated that the activator must be somewhat resistant to chymotrypsin. However, the working assay showed that considerable activity was rapidly lost in the presence of less than one microgram of chymotrypsin per ml., a concentration exceeded in most activation experiments. On the other hand, preliminary tests showed that the capacity to activate chymotrypsinogen was retained, as was the capacity to activate prothrombin in the presence of oxalate.
Another suggestion of selective inactivation appeared when a preparation of human thrombokinase was tested for Dr. D. L. Aronson of the National Institutes of Health. It was strong when tested in the oxalated system; but relatively weak in the working assay. At that time Aronson and Menache had already encountered molecular variants of prothrombin ;U and the possibility of a molecular variant of thrombokinase was considered. Since then, Dr. Aronson has indicated (personal communication) that variable proportions of such a variant appear to be present in his preparations of human thrombokinase.
In a previous study,1' gel filtration of thrombokinase failed to separate activities associated with thrombokinase; and results with recent gel filtrations have been similar when fresher preparations have been analyzed. With some older preparations of thrombokinase, however, gel filtration has yielded some evidence of separation. This is illustrated in Figure IA .
Step-7 thrombokinase, which had been stored for 53 months at -23'C, was concentrated by precipitation with ammonium sulfate1' and dialyzed against veronal-buffered saline. It then had 1523 TAMe units and 5.9 mg. protein per ml.; and it was stored at -23'C. For the experiment of Figure IA it was thawed, and a portion was mixed with 1/9 volume of veronal-buffered saline. After the mixture was chilled, 1.0 ml. was introduced into the cold column of Sephadex, superfine G-100. The gel was 39.7 cm. high; and a hydrostatic pressure of 11 cm. gave a flow-rate of 8.5 ml. per hour. Fractions of 3.0 ml. were collected automatically by counting 102 small drops per fraction.
In Figure IA , it can be seen that the principal protein peak occurs in the same fraction as the three activity peaks. The protein peak has a shoulder on the trailing side. Under this shoulder the activity curves for kinase and esterase tend to follow the protein curve; and they cross over the workingassay curve, which falls without a shoulder. Beyond the crossing, the ratio of kinase to working assay is higher than before the crossing. It is the shoulder that might represent a molecular variant of thrombokinase.
Two days later, the same concentrated thrombokinase was thawed; and a portion was mixed with 1/9 volume of chymotrypsin in 0.001N HCI. The concentration of chymotrypsin was one microgram per milliliter of mixture. Samples were taken at 2 minutes and 82 minutes for activity tests. Incubation during this interval was at 30'C. Then the mixture was chilled 15 minutes in an ice bath and 60 minutes at 4.5°C.; and 1.0 ml. was introduced into the same column as that used for Figure IA . Other than the chilling and the column fractionation in the cold, nothing was done to stop the action of chymotrypsin on thrombokinase. The gel column was 39.6 cm. high; and a hydrostatic pressure of 11 cm. gave a flow-rate of 8.5 ml. per hour. Fractions of 3.0 ml. were collected automatically by counting 102 small drops per fraction. Table 1 summarizes the results of the activity tests on thrombokinase after incubation with chymotrypsin, but before gel filtration. In 80 minutes with chymotrypsin at 30°C, 81%o of the activity as measured by the working assay was lost; but only 12%o of thrombokinase as measured by activation of prothrombin in the presence of oxalate was lost. Losses of chymotrypsinogen activator and esterase were likewise small. Figure 1B depicts the gel filtration of the chymotrypsin-treated thrombokinase. There it is seen that most of the protein emerged from the column in the position formerly occupied by the shoulder of Figure 1A ; and there is now only a little protein in the position formerly occupied by the protein peak. In contrast, the curve for the activity measured by the working assay, See section on MATERIALS AND METHODS for details of assays.
although now much lower, is in about the same position as that occupied by the corresponding curve of Figure 1A . It has become much smaller, but has not shifted its position, whereas the other activity curves have taken new positions in parallel with the new protein peak, but they have not become much smaller. Meanwhile, barely perceptible rises in Figure IA have become definite humps at 120 and 138 ml. in Figure 1B . Conceivably, they represent smaller fragments produced by the action of chymotrypsin. There has been less change in the large-particle material that has emerged from both columns immediately after the void volume at 73 ml. The concentration of chymotrypsin as protein was so minute that it would not contribute directly and significantly to the optical density of any effluent fractions in which it emerged.
The foregoing experiments indicate that a molecular modification occurred in the thrombokinase as a result of treatment with chymotrypsin and that there was a concomitant selective loss of activity. They further suggest that a similar variant thrombokinase occurs in some preparations to which no enzyme has been added. In Figure 1A , this is represented by a shoulder on the protein peak. In the most extreme case encountered so far, enough molecular variant to give another peak has been present "spontaneously." This is shown in Figure 2 .
Step-7 thrombokinase, which had been stored for 52 months at -23°C, was thawed, concentrated by ultrafiltration and dialyzed against veronal-buffered saline. It then had 2800 TAMe units and 10.2 mg. protein per ml.; and it was stored at -23°C. For-the experiment of Figure 2 , it was thawed, and a portion was mixed with 1/9 volume of veronal-buffered saline. After the mixture was chilled, 1.0 ml. was introduced into the column of Sephadex, superfine G-100 at 4.5°C. The gel was 39.7 cm. high; and a hydrostatic pressure of 11 cm. gave a flow-rate of 9.0 ml. per hour. Fractions of 3.0 ml. were collected automatically by counting 102 small drops per fraction. This experiment was marred by the occurrence of considerable foaming during ultrafiltration and by a power failure which made it necessary to stop the column flow for 45 minutes. However, an uninterrupted run on another sample of the same preparation, which had not been concentrated or foamed, gave a similar separation of two peaks. Figure 2 shows the occurrence of two peaks, of which the first corresponds to that of Figure 1A and the second has a position close to that of Figure 1B . Most of the activity measured by the working assay is associated with the first peak, whereas kinase and esterase are divided almost equally between the two peaks.
The selective separation of activities was such that the ratio of working assay to thrombokinase was 29 times as great at 91 ml. as it was at 100 ml. Tests for thrombokinase in the presence of oxalate were done with each fraction at a final dilution of 1 :50; and the activity was about the same in the two fractions. However, in the working assay, the fraction at 91 ml. was tested at a dilution of 1 :1,000,000; whereas the fraction at 100 ml. had about the same activity at a dilution of 1:30,000. Although the working assay was thus only 3%o as great at 100 ml. as at peak level, activity was still demonstrable at high dilution because of the sensitivity of the test. Nevertheless, the 3%o level might merely represent spreading at the base of the first peak. How much of this activity actually belongs to the thrombokinase of the second peak cannot be decided on the basis of present data. Nor can it be determined whether there is an intermediate series of variants.
The basis for the "spontaneous" occurrence of variant thrombokinase is not clear. The age of the preparation may not be the most important determining factor. Variant thrombokinase has also been found in fresher material that had been prepared by a modified procedure. And there has not been enough experience to determine how free of variants an aged preparation can be. Nor is it known how closely the variant occurring "spontaneously" resembles that produced by chymotrypsin.
In separate runs on the same column of Sephadex, elution volumes for chymotrypsinogen A, egg albumin and bovine plasma albumin were determined to be 113.6, 95.6 and 85.5 ml., respectively. The void volume was found to be 73.2 ml. in runs made with Blue Dextran. These data are plotted according to the method of Whitaker' in Figure 3 . There it is seen that there is a linear relation between molecular weight and ratio of elution volume to void volume for the three reference proteins, which are taken to have molecular weights of 25,000, 45,000 and 65,000, respectively. The elution volumes for the different forms of thrombokinase could be estimated with varying degrees of accuracy. In Figure 1A , Figure 1B and Figure 2 , the elution volumes of the first peak were 89.5, 89.8 and 89.5 ml., respectively. After treatment with chymotrypsin, the elution volume of the predominant protein was 96.6 ml., as seen in Figure 1B . The variant thrombokinase in old preparations had elution volumes of 97.0 and 97.1 ml., as seen in Figure 1A and Figure 2 , respectively. The arrows in Figure 3 indicate where the corresponding ratios would fall on the reference line. Ac-cording to this, thrombokinase -emerged from the column in the position characteristic of "typical proteins" of molecular weight about 56,000. After treatment with.chymotrypsin, its position corresponded to that of "typical proteins" of molecular weight about 44,000; and the variant occurring "spontaneously". was, in this respect, close to that produced by chymotrypsin. DISCUSSION The isolation of thrombokinase was first described in 1960.-However, there was no analysis in the ultracentrifuge. Rather, the evidence of isolation was the close approach to electrophoretic homogeneity and the un- usually high clotting activity. Moreover, as later detailed,' there was in the case of the first isolation a constant specific activity, within experimental error, across the electrophoretic peak. During the course of repeated electrophoretic fractionations, it had been demonstrated that thrombokinase had the capacity to hydrolyze TAMe; and the specific activities were reported in terms of this reaction. It was then found' that thrombokinase was one of the last proteins to be eluted from DEAE-cellulose; and chromatography on DEAE-cellulore was substituted for the first two of the three electrophoretic fractionations. The isolation procedure then ended with chromatography on DEAE-cellulose followed by paper curtain electrophoresis. This material had the same TAMe esterase activity, within experimental error, as previously reported; and it gave a single boundary in the analytical ultracentrifuge.' However, no estimate of molecular weight was published.
Esnouf and Williams first reported the isolation of bovine factor X in 1961.' They remarked on the striking parallel between the factor X-activated factor X and the prothrombokinase-thrombokinase systems, and noted the similar behavior on DEAE-cellulose. Since then, it has been widely considered probable that factor X is the equivalent of prothrombokinase. On the basis of sedimentation and diffusion data, Esnouf and Williams estimated the molecular weight of plasma factor X to be 86,000. They also obtained factor X from bovine serum, apparently still in the precursor form, and reported it to have a molecular weight of 36,000. Recently, large-scale purification of bovine factor X has been described by Jackson, Johnson, and Hanahan.' This material has been reported to have a molecular weight about 55,000 by Jackson and Hanahan,ls who also described two kinds of active molecular variants, detectable by disc electrophoresis and chromatography, respectively. They further considered the possibility of an inactive factor X, electrophoretically indistinguishable from the active species. The apparent molecular weight (size) by gel filtration on Sephadex G-100 was given as 80,000-90,000, with distinguishable variants within this range. The gross difference of this range from the molecular weight determined by Jackson and Hanahan from sedimentation equilibrium data was ascribed by them to the asymmetry of the factor X protein, which led to "atypical" behavior on gel filtration. Regardless of the reasons for the diversity in the other estimates of molecular weight, it is quite clear that molecular variants of factor X do exist.
The precursor molecule can be activated through proteolysis by Russell's viper venom or trypsin, and apparently becomes smaller in the process.'
It is generally supposed, but not proven, that physiologic activators function similarly. Seegers, Cole, Harmison, and Marciniak' have suggested that the order of magnitude for the molecular weight of autoprothrombin C is about 24,000. However, it has been recognized that although thrombokinase, autoprothrombin C and activated factor X activities may appear to be equivalent, the molecules possessing these common biologic activities as one of their properties may not be identical.' The present findings emphasize that thrombokinase can vary not only in its physico-chemical properties, but also in the proportion of its variously measured activities. It is of especial interest that the activity destroyed preferentially by chymotrypsin was that measured by the working assay, i.e., the one in which ionic calcium, phospholipid and factor V were added, and thus the one most like the assays more recently used for activated factor X and autoprothrombin C. This selective loss was accompanied by a change in gel filtration properties, which may in turn reflect a change in structure or conformation. How complete the loss was, and whether it occurred all at once or in stepwise fashion, are some of the questions remaining for the future.
Treatment with chymotrypsin is one way of bringing about such a molecular change in thrombokinase. When a comparable variant occurs in thrombokinase to which no chymotrypsin has been added, the possible action of naturally-occurring enzymes must be considered, as well as non-enzymatic changes. For this question, the data are as yet insufficient to support a decision.
SUMMARY
Thrombokinase, prepared from bovine plasma, was incubated with a minute amount of chymotrypsin. It thereupon lost most of its activity in the assay with prothrombin, calcium chloride, phospholipid, and factor V. However, it retained most of its activity in three other assays: 1. activation of prothrombin in the presence of oxalate, 2. activation of chymotrypsinogen, and 3. hydrolysis of tosylarginine methyl ester. Such treated thrombokinase emerged from a gel filtration column in the position characteristic of "typical proteins" of molecular weight of about 44,000, whereas before treatment with chymotrypsin it had emerged in the position characteristic of "typical proteins" of molecular weight about 56,000. While there is thus evidence of some molecular change, no conclusions are drawn about the molecular weights of the different forms of thrombokinase, since they may not be "typical proteins" with respect to gel filtration. Protein similar to that of treated thrombokinase in behavior on gel filtration and in activity tests, was found along with the principal protein in some thrombokinase preparations to which no chymotrypsin had been added.
